A prospective randomised controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE
Latest Information Update: 25 Mar 2019
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Antiphospholipid syndrome; Thrombosis; Venous thromboembolism
- Focus Pharmacodynamics
- Acronyms RAPS
- 22 Mar 2019 Status changed from active, no longer recruiting to completed.
- 19 Aug 2016 Results assessing complement activation markers, published in the Journal of Thrombosis and Haemostasis
- 06 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network